Radioligand therapy is transforming oncology by delivering targeted radiation directly to tumors while sparing healthy tissue ...
AZD8055（AbMole，M1666）是一种选择性的ATP竞争性mTOR激酶抑制剂，通过结合mTOR激酶的ATP结合口袋，同步抑制mTORC1与mTORC2复合物活性，显著降低AKT（Ser473与Thr308）、S6K1、4E-BP1等下游分子 ...
Standardized criteria in PSMA PET/CT for patient selection for 177 Lu-PSMA radionuclide therapy (RNT) have been established, but further refinement to enhance therapeutic responses is warranted.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果